Myovant Stock Falls 19% After FDA Faults Endometriosis Drug Application
(Myovant) Shares of Myovant Sciences fell more than 19% on Tuesday after the US Food and Drug Administration cited deficiencies in filing for an endometriosis drug. FDA did not offer…